See every moment in surgery
The first smart, single-use lens-cleaning device co-developed with Mayo Clinic that restores surgical clarity in real-time, without withdrawing the scope.
The Problem
Surgery's oldest problem.
Finally solved.
For decades, surgeons have relied on a century-old workaround for compromised visibility: removing the laparoscope, wiping the lens, reinserting it mid-procedure. These interruptions contribute to errors, complications and unnecessary burden on surgeons, patients and systems.
No standardised solution has existed, until now.
3m+
MIS procedures performed annually in the US alone.1
1. Mattingly AS, Chen MM, Divi V, Holsinger FC, Saraswathula A. "Minimally Invasive Surgery in the United States, 2022: Understanding Its Value Using New Datasets." J Surg Res. 2023;281:33–36. doi: 10.1016/j.jss.2022.08.006
120k
patients annually affected by visualisation-related incidents in the USA2
2. Uecker JM et al. "Blurred vision, clear concern: linking poor visualization with adverse events in minimally invasive surgery." Surgical Endoscopy. 2025. doi: 10.1007/s00464-025-12052-1
$2.2B
annual cost in the US alone3
3 Dhingra J et al. "Clear Vision, Clear Savings: Enhancing Efficiency in Minimally Invasive Surgery." JSLS. 2025;29(3):e2025.00023. doi: 10.4293/JSLS.2025.00023
72%
of visualisation-related incidents resulted in patient injury2
2. Uecker JM et al. "Blurred vision, clear concern: linking poor visualization with adverse events in minimally invasive surgery." Surgical Endoscopy. 2025. doi: 10.1007/s00464-025-12052-1
Up to
50%
of total operative time impacted by compromised vision3, 4
3. Dhingra J et al. "Clear Vision, Clear Savings: Enhancing Efficiency in Minimally Invasive Surgery." reports 40%+ of MIS time under suboptimal visualization; JSLS. 2025;29(3):e2025.00023. doi: 10.4293/JSLS.2025.00023
4. Corroborated by Łącki M et al., Frontiers in Surgery, 2025, doi:10.3389/fsurg.2025.1576422 (range across studies: 19–52.5%)
61%
of surgeons witnessed an error linked to compromised vision5
5. Nabeel A, Al-Sabah S, et al. "Assessing and evaluating the impact of operative vision compromise (OViC) on surgeons' practice — a qualitative study." International Journal of Surgery. 2024;110(11):6972–6981. doi:
10.1097/JS9.0000000000001958
Technology
Surgical clarity when it matters most
Using advanced temperature controls, a precision burst of fluid, and our patented jet-drying technology, Klens cleans the laparoscopic lens while it remains inside the patient. The procedure continues without interruption
Without Klens
With Klens
Clinical Data
The evidence is clear
Compromised vision consumes up to 44% of laparoscopic procedure time. In robotic surgery, that figure climbs to 55%. This is a major structural inefficiency in modern surgery.
Operative Vision Compromise Study
Assessing and evaluating the impact of operative vision compromise (OViC) on surgeons' practice: a qualitative study.
View studyEndoscopic Lens Cleaning Review
Effective cleaning of endoscopic lenses to achieve visual clarity for minimally invasive abdominopelvic surgery: a systematic review.
View studyTeam
Built by people who understand the problem from the inside
Ahmad Nabeel
CEO & Founder
Physician-scientist. PhD in Surgical Vision, Imperial College London. Named an 'Innovator Under 35' by MIT Technology Review. Ahmad spent years researching this specific problem before building the device to solve it.
Joe Gordon
Chief Technology Officer
Joe leads all technical development at Klens from device architecture to clinical integration. He has over 20 years of experience years across robotics, audiology, and endoscopy - with over 50 patents in that period. Add in a new sentence.
Nadeem Schwen
General Counsel
Deep expertise in IP, patent law, and data privacy - with a computer engineering background that means he understands the technology he protects. Instrumental in building Klens' IP portfolio.
Joe Kiani
Board Member, founder of Masimo
"When I first saw Klens in action, I knew immediately this was the kind of technology that changes the standard of care, not incrementally, but fundamentally. Ahmad has built something that solves a real, daily problem in surgery. I'm proud to back Klens and to help Ahmad take it to surgeons and patients around the world."
Backed by the people who have changed healthcare
Dr. Michael Kendrick
Chair of Surgery, Mayo Clinic
World authority in minimally invasive and robotic surgery.
Dr. Ali Aminian
Director, Bariatric and Metabolic Institute, Cleveland Clinic
Leading voice in laparoscopic and robotic surgery. Key opinion leader in the field.
Dr. Philip Schauer
Executive Director, Metamor Institute
Pioneer of bariatric surgery. Former President of the American Society for Metabolic and Bariatric Surgery
Dr. Hutan Ashrafian
Chief Medical Officer, Harbinger Health
500+ peer-reviewed publications. Former Chief Scientific Adviser, Imperial College London. One of the most published surgeon-scientists of his generation.
Partners
Working with the institutions that set the standard
Our partnerships span leading medical institutions, regulatory bodies, and top-tier medical device development firms worldwide.
Mayo Clinic
American College of Surgeons
Imperial College London
Veranex
Institute of Global Health Innovation
Ximedica
Pennington Biomedical
Hamlyn Centre
IP Portfolio
The technology is ours.
Over 20 filings protect every element of the Klens technology — from thermal control to jet-drying — ensuring our innovations remain exclusive as the platform scales globally.
20+
Patent filings
6
Continents protected
